{"ticker": {"uuid": "36182664-2467-40f8-926b-c06cc8197be3", "symbol": "NTRB", "name": "Nutriband Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Price to book forward of Nutriband Inc. \u2013 NASDAQ:NTRBW", "summary": "This article provides financial information for Nutriband Inc. (NASDAQ: NTRBW), specifically focusing on its price-to-book forward ratio. It appears to be a financial data snippet from TradingView, indicating the company's valuation metric without further detailed analysis in thi", "url": "https://www.tradingview.com/symbols/NASDAQ-NTRBW/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-07-14T08:15:32", "published_display": "14 Jul 2026 08:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Nutriband Inc. \u2013 NASDAQ:NTRBW", "summary": "This article provides access to the \"Enterprise value to EBIT forward\" financial metric for Nutriband Inc. under the NASDAQ:NTRBW ticker symbol. It appears to be a financial data page from TradingView, offering an overview of the company's financials for market analysis. The page", "url": "https://www.tradingview.com/symbols/NASDAQ-NTRBW/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-14T05:12:48", "published_display": "14 Jul 2026 05:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband Inc. (NTRB) Slips 2.33% as Stock Tests Key Support at $2.79 - Sweep Order Flow", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPMHg5N0QwXzhpbXU0bEJLM2hmbzJiMGNTS2VBMzNtUTk0SjVUQnJKYlFCVlpLQ0x1ajRaY2xiT0ctbDF2UTJCRlcyZXVFWVNNbEhVc3lCQ2p0RkgtX2lIdkxGblRUdTlFM0N4dldvbmVTTm5hY1FOZVROd3pCeXozcG5iMXhwYU84SkItOTEtdWthbGRsWkdKclRrZDI2dFJncXdpUQ?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-13T14:48:00+00:00", "published_display": "13 Jul 2026 14:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Nutriband Inc. \u2013 NASDAQ:NTRBW", "summary": "This article focuses on the enterprise value to EBITDA forward for Nutriband Inc. (NASDAQ: NTRBW). It provides a financial metric for the company, indicating its valuation relative to its future earnings before interest, taxes, depreciation, and amortization. The content appears ", "url": "https://www.tradingview.com/symbols/NASDAQ-NTRBW/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-07-13T15:11:06", "published_display": "13 Jul 2026 15:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Enterprise value to EBITDA forward of Nutriband Inc. \u2013 BOATS:NTRBW", "summary": "This article displays the \"Enterprise value to EBITDA forward\" for Nutriband Inc. under the symbol NTRBW on the Blue Ocean Alternative Trade System. It provides no specific financial data but indicates this metric as part of the company's financial overview on TradingView.", "url": "https://www.tradingview.com/symbols/BOATS-NTRBW/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-07-09T10:13:50", "published_display": "09 Jul 2026 10:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Nutriband Inc. \u2013 BOATS:NTRBW", "summary": "This article provides the \"Price to earnings forward\" financial data for Nutriband Inc. (NTRBW) on the Blue Ocean Alternative Trade System (BOATS). It shows that the market is currently closed with no trades recorded. The content is primarily a data point display within the Tradi", "url": "https://www.tradingview.com/symbols/BOATS-NTRBW/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-08T21:10:13", "published_display": "08 Jul 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Nutriband Inc. \u2013 BOATS:NTRBW", "summary": "The article displays the \"Price to sales forward\" financial metric for Nutriband Inc. (NTRBW) on the TradingView platform. It indicates that the market is closed and there are no trades shown for the company. The content primarily features navigation links and information about t", "url": "https://www.tradingview.com/symbols/BOATS-NTRBW/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-08T11:40:54", "published_display": "08 Jul 2026 11:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband Inc (NTRB) Valuation: PE, PB & Fair Value Analysis", "summary": "This article provides a valuation analysis of Nutriband Inc (NTRB), noting its current valuation score of 6.58, ranking 181 out of 203 in its industry. It highlights the company's P/E ratio and mentions that relevant data for P/B, P/S, and P/CF ratios have not yet been disclosed.", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ntrb/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-26T02:39:18", "published_display": "26 Jun 2026 02:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Nutriband Inc. \u2013 NASDAQ:NTRB", "summary": "This article focuses on the \"Price to sales forward\" metric for Nutriband Inc. (NASDAQ: NTRB) as presented on TradingView. It appears to be a financial data point for the company, accessible through the platform's tools for market analysis. The core content is limited to this spe", "url": "https://www.tradingview.com/symbols/NASDAQ-NTRB/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T21:11:24", "published_display": "25 Jun 2026 21:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband Inc (NTRBW) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Nutriband Inc (NTRBW), detailing its support, resistance, and various indicators. It shows that based on technical indicators like MACD, RSI, and moving averages, the current signal for NTRBW is primarily \"Sell\" with more sell signals", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ntrbw/technical", "source_name": "TradingKey", "published_at": "2026-06-25T02:39:19", "published_display": "25 Jun 2026 02:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Nutriband Inc. \u2013 NASDAQ:NTRB", "summary": "This article provides a financial data point for Nutriband Inc. (NASDAQ: NTRB), specifically its forward price-to-earnings ratio. The content presented is a snippet from TradingView's financial overview for the company, indicating the period, value, and change of this metric. It ", "url": "https://www.tradingview.com/symbols/NASDAQ-NTRB/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-24T06:40:14", "published_display": "24 Jun 2026 06:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NutriBand amends $5 million credit line facility for three more years", "summary": "NutriBand Inc. has announced an amendment to its $5 million credit line facility, extending it for three more years. The new agreement, which commenced on June 1, replaces a previous facility set to expire in July 2026, and features a 7% interest rate on drawdowns without convers", "url": "https://www.investing.com/news/sec-filings/nutriband-amends-5-million-credit-line-facility-for-three-more-years-93CH-4752601", "source_name": "Investing.com", "published_at": "2026-06-22T13:10:08", "published_display": "22 Jun 2026 13:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NutriBand Secures Amended Three-Year $5 Million Credit Line at 7% to Support AVERSA", "summary": "NutriBand (NTRB) has secured an amended three-year, $5 million credit line with a 7% interest rate. This financial agreement is intended to support the company's AVERSA fentanyl transdermal system through FDA approval and into commercial-scale manufacturing. The new facility repl", "url": "https://www.tradingview.com/news/tradingview:db7fb35430ac6:0-nutriband-secures-amended-three-year-5-million-credit-line-at-7-to-support-aversa/", "source_name": "TradingView", "published_at": "2026-06-22T12:10:08", "published_display": "22 Jun 2026 12:10", "sentiment": "positive", "sentiment_pct": 67, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[8-K] NutriBand Inc. Reports Material Event", "summary": "NutriBand Inc. (NTRB) has secured an amended three-year $5,000,000 credit line facility, replacing an expiring one, with an interest rate of 7% per annum on drawdowns. This financing is structured as straight debt, avoiding potential equity dilution, and is intended to fund the F", "url": "https://www.stocktitan.net/sec-filings/NTRB/8-k-nutri-band-inc-reports-material-event-f823572f6896.html", "source_name": "Stock Titan", "published_at": "2026-06-22T12:10:08", "published_display": "22 Jun 2026 12:10", "sentiment": "positive", "sentiment_pct": 64, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 8K Nutriband Inc For: 22 June By Investing.com", "summary": "This article reports that Nutriband Inc. filed a Form 8K on June 22, 2026. The SEC filing is noted as a key event for investors tracking the company, with its stock, NTRB, showing a 7.24% increase.", "url": "https://au.investing.com/news/stock-market-news/form-8k-nutriband-inc-for-22-june-93CH-4497674", "source_name": "Investing.com Australia", "published_at": "2026-06-22T10:10:09", "published_display": "22 Jun 2026 10:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[8-K] NutriBand Inc. Reports Material Event | NTRB 8-K Filing", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPLVh3cTRYMEstVl9pQVpWNkRyc29TYjNyd1NZOGt6Nk9GdkNmbWlnbzdnWGJBOFNLQ25fYm1WOGZxcXV5Y3hhSHpLYVVSclkwN2xkeHM1SEVvVUJIaE54YzRSMGRUVlJmQXlnTXpqMTlmUFg0aXR6VGlIQkI0dnJ3eXZGem0za3R4ejdxdHJXQkp5OUhzR3FIb3lvclZxRDRQZlYxc1dn?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband Inc (NTRBW) Risk Assessment: Volatility, Financial Risk & Investment Risk", "summary": "This article provides a risk assessment for Nutriband Inc (NTRBW), detailing various volatility and return metrics. It includes data points such as Beta vs S&P 500 index, maximum drawdown, daily returns, Sharpe Ratio, and different measures of volatility and liquidity. This infor", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ntrbw/risk-assesment", "source_name": "TradingKey", "published_at": "2026-06-19T07:39:41", "published_display": "19 Jun 2026 07:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband Inc (NTRBW) Institutional Confidence", "summary": "This article provides an overview of the institutional confidence in Nutriband Inc (NTRBW), detailing key institutional shareholders and their recent activity. It lists prominent firms like Citadel Advisors LLC, Virtu Americas LLC, Clear Street LLC, UBS Financial Services, Inc., ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ntrbw/sentiment", "source_name": "TradingKey", "published_at": "2026-06-19T03:39:41", "published_display": "19 Jun 2026 03:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband Inc (NTRBW) Financial Health: Profitability & Balance Sheet Analysis", "summary": "This article provides a financial health overview for Nutriband Inc (NTRBW), noting its current stock price and a significant daily decrease. It highlights that critical financial data regarding profitability, balance sheet, quality of earnings, operational efficiency, growth pot", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ntrbw/financial-health", "source_name": "TradingKey", "published_at": "2026-06-19T03:39:41", "published_display": "19 Jun 2026 03:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband Inc (NTRB) Institutional Confidence", "summary": "This article provides details on Nutriband Inc.'s (NTRB) institutional confidence, highlighting a score of 3.00 as of June 17, 2026. It lists key shareholders and their recent activity, showing increases in shares held by several individuals and entities, such as Botgros (Vitalie", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ntrb/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T08:10:38", "published_display": "18 Jun 2026 08:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband Inc (NTRBW) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article provides an overview of Nutriband Inc (NTRBW) shareholder structure, detailing institutional holdings and major shareholder activity. It presents data including the number of institutions and shares held over several reporting periods, as well as changes in holdings ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ntrbw/ownership", "source_name": "TradingKey", "published_at": "2026-06-18T06:09:47", "published_display": "18 Jun 2026 06:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband Inc (NTRBW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article from TradingKey attempts to provide a revenue breakdown for Nutriband Inc (NTRBW), detailing business segments, regional revenue, and profit contribution. However, the article explicitly states that the relevant data has not been disclosed by the company yet, renderi", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ntrbw/revenue", "source_name": "TradingKey", "published_at": "2026-06-18T05:09:47", "published_display": "18 Jun 2026 05:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband Inc (NTRBW) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides a detailed historical record of dividend payouts and stock splits for Nutriband Inc (NTRBW). It indicates that the company has not distributed any dividends over the past five years and has no recorded stock split events. The page also includes real-time sto", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ntrbw/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-18T05:09:47", "published_display": "18 Jun 2026 05:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband Inc (NTRB) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article from TradingKey provides a concise overview of Nutriband Inc's (NTRB) dividend history and stock split events. It indicates that Nutriband Inc has not distributed any dividends over the past five years. The only recorded stock split event for NTRB was on July 29, 202", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ntrb/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-18T00:40:36", "published_display": "18 Jun 2026 00:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband Inc (NTRB) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "Nutriband Inc (NTRB) has an earnings forecast score of 8.00, placing it well within its industry. A single analyst rates NTRB as a \"Buy\" with a target price of $15.00, suggesting a significant upside. The article provides current trading data, key financial metrics, and a peer co", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ntrb/earnings", "source_name": "TradingKey", "published_at": "2026-06-17T16:09:10", "published_display": "17 Jun 2026 16:09", "sentiment": "positive", "sentiment_pct": 70, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[10-Q] NutriBand Inc. Quarterly Earnings Report", "summary": "NutriBand Inc. (NTRB) filed its quarterly earnings report (10-Q) for the period ended April 30, 2026, showing a net loss of $1,241,956, or $0.10 per share. The company generated $433,399 in revenue, primarily from its Pocono Pharmaceuticals segment, with no revenue from 4P Therap", "url": "https://www.stocktitan.net/sec-filings/NTRB/10-q-nutri-band-inc-quarterly-earnings-report-d4e7622ab80d.html", "source_name": "Stock Titan", "published_at": "2026-06-11T20:39:55", "published_display": "11 Jun 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband Inc. (NTRB) Slips Modestly as Stock Tests Key Support Levels - Rating Change", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPbko3Q0RsWkp3cDBpaUNmekpZMlJLQlFsVVBnNUFvc2RIcm42VGFXektxX1Z3dTJ2VkVZNExNOWhBdm53cWx5TUJRcFRCeXNIMHVVRHZZVG5NOFp5LUZYV1dja1VGdmM0dWpVSWRmd3doV2EzNnpDUzB3NVhTWExlSjRYNGtLS0QtbTlDNk1WcExtSnp5WUNiaTR1WTZYZHRWb1VCOXFrQjNDSmdPZzlCbzJ6aUI5QQ?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Number of shareholders of Nutriband Inc. \u2013 NASDAQ:NTRBW", "summary": "This article provides access to the number of shareholders for Nutriband Inc. (NASDAQ: NTRBW) through TradingView's platform. It mentions that market data is provided by ICE Data Services, reference data by FactSet, and SEC filings by Quartr. The core content linked is about the ", "url": "https://www.tradingview.com/symbols/NASDAQ-NTRBW/financials-statistics-and-ratios/number-of-shareholders/", "source_name": "TradingView", "published_at": "2026-06-07T06:40:21", "published_display": "07 Jun 2026 06:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband Inc. announced that it has received $5 million in funding", "summary": "Nutriband Inc. announced it has received $5 million in funding through a creditline promissory note issued on June 1, 2026. This funding comes from a new lender, T.I.I.-Jetservices, Lda., with the note carrying a 7% interest rate and maturing on July 1, 2029. The accrued interest", "url": "https://www.marketscreener.com/news/nutriband-inc-announced-that-it-has-received-5-million-in-funding-ce7f5fdad88af522", "source_name": "www.marketscreener.com", "published_at": "2026-06-03T00:39:04", "published_display": "03 Jun 2026 00:39", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NTRB - Nutriband Inc Stock Price and Quote", "summary": "This page provides a comprehensive overview of Nutriband Inc. (NTRB) stock, including its current price, financial metrics, analyst ratings, and a detailed list of recent news and corporate actions. It highlights the company's focus on transdermal pharmaceutical products, particu", "url": "https://finviz.com/stock?t=NTRB", "source_name": "Finviz", "published_at": "2026-06-01T03:40:06", "published_display": "01 Jun 2026 03:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband, Inc. Stock Plummets to New 52-Week Low of $3.28", "summary": "Nutriband, Inc. stock has fallen to a new 52-week low of $3.28, reflecting significant financial challenges in the Pharmaceuticals & Biotechnology sector. The company reported a 42.03% decline in net sales and a 47.4% net profit loss, resulting in a negative return on equity of 1", "url": "https://www.marketsmojo.com/news/stocks-in-action/nutriband-inc-stock-plummets-to-new-52-week-low-of-328-4020949", "source_name": "Markets Mojo", "published_at": "2026-05-29T18:39:16", "published_display": "29 May 2026 18:39", "sentiment": "negative", "sentiment_pct": 19, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband Inc.'s Equity Buyback announced on September 18, 2024, has expired.", "summary": "Nutriband Inc.'s equity buyback program, which was originally announced on September 18, 2024, has now expired. The company officially ended its plan on January 31, 2026. This announcement highlights the conclusion of their share repurchase initiative.", "url": "https://www.marketscreener.com/news/nutriband-inc-s-equity-buyback-announced-on-september-18-2024-has-expired-ce7f5ad2d08ef622", "source_name": "www.marketscreener.com", "published_at": "2026-05-29T08:39:16", "published_display": "29 May 2026 08:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband, Inc. Stock Plummets to New 52-Week Low of $3.38", "summary": "Nutriband, Inc. (NTRB) has hit a new 52-week low of $3.38, with its stock declining 41.25% over the past year. The microcap pharmaceutical company faces challenges including a negative return on equity, concerning operating cash flow of -$5.64 million, and rising raw material cos", "url": "https://www.marketsmojo.com/news/stocks-in-action/nutriband-inc-stock-plummets-to-new-52-week-low-of-338-4018695", "source_name": "Markets Mojo", "published_at": "2026-05-29T02:08:59", "published_display": "29 May 2026 02:08", "sentiment": "negative", "sentiment_pct": 20, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband Inc to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/nutriband-inc-showcase-expanding-ai-110000540.html", "source_name": "GlobeNewswire", "published_at": "2026-05-15T11:00:00+00:00", "published_display": "15 May 2026 11:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl Crisis and Company Update on Latest Episode of the Jack Neel Podcast", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/nutriband-ceo-gareth-sheridan-discusses-110000956.html", "source_name": "GlobeNewswire", "published_at": "2026-04-22T11:00:00+00:00", "published_display": "22 Apr 2026 11:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Nutriband Selects Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxOZEloM2lPVjE2ZkRQbkVld0t0UU5pZlRvNzNBVnRzbjBHMVdxbzduaWNUejFaMVVWT3VpVno2UlkwbUpncTd3dERGQVFZb085RFZaaEJubXREcEY5Y3BZVkJxR1lkVGxGbGVrZzRpWkliYnFpZmthU1JNZWtIZFJDQm4tcmFYYkpMdWl0T3Q0VVc0NldaVUFITUZlSVhzQ1VSeHN0VkI3SF9uYlhzQ2xJZFZCaDZyaWdGcnpTV2dWTEdtdG83Z3BSRXhpdFl2b3ItTjJwMmZrQkt2bzBDRWlvbGNXek4?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-03-30T07:00:00+00:00", "published_display": "30 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "The past five years for Nutriband (NASDAQ:NTRB) investors has not been profitable", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxPd0FZQ29mcGJlbHBrdzNWSnZlTU5hNkRyTmZLYy1sRmFTQmlxQ2FGS3FMYzJ1NGZESWl4MTRiSFUyWk1sb2pxTTlIdzhOcmtmRXpyZF82ZGMwUFVtbmpPeGZaY1h4OHRxcDZnUkhDTXI1VThBMk5fMHV5RTkycXFLN2NSNUw?oc=5", "source_name": "Market source", "published_at": "2026-01-29T08:00:00+00:00", "published_display": "29 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband responds to Trump\u2019s designation of illicit fentanyl as WMD", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPNXhhUVJ6UFNiZjhsY0lsbTBZekZwMkpuazJwX0tYQXJPQTd4SGZTb3FJbWZvVDM1Q0xQLUJnbzZHUjRpZ0FEbUZMSkp4aUFPZmtiWElRUWtLT05PQ3cxYUJscGJvWWdBSVVPdDlEREQ1RTNrSHNoOUoya2ItazFwa3FYNlpVNlFObnNWQzFuVllCdXhQelRiQW9GaEw5TTFLT1pGWVVHX21ERVVzTWIzRXRlaC1ra3llaGVaS1hWUW1jUQ?oc=5", "source_name": "Investing.com", "published_at": "2025-12-18T08:00:00+00:00", "published_display": "18 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband (NASDAQ: NTRB) Reports 51% Revenue Growth, Strong Cash Position to Advance AVERSA Fentanyl", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgJBVV95cUxQdUhQR291bHFfYXIwZTJwR19SQjhBTFdzUjVnTWd5ZVBSeVF5M25iN2NsOW1ZVkdBb3hKWWhoOHdYMndFNzgwamVhcERZNXZIeF9lUzI3NzdwR0x4cHpXVFRLMnc5UnpBVmlGOXFnb1pWRVc5YUkyZ2lsTFhXdUltbkFaeDhTTzZIc3dDWmNkN0p0NmhZSUtTc3pZWWNDN002UF9IQWlaY19XdjI3eXNSUUxmM180NDlDNHpPV2NKYWQzTHhPVGo2d1E1V3ZzaU5JQTBxTV9XMkpqM3h1SnN2OWJhdGRrOWh5TGZrdWRua2dPN1JUakVaQ29Ia0FxTXQtX2xXTGVNcnlzdjFRSUE?oc=5", "source_name": "The Globe and Mail", "published_at": "2025-09-11T07:00:00+00:00", "published_display": "11 Sep 2025 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband CEO Gareth Sheridan: \u201cThe economy is booming, but that\u2019s a punch to the gut \u2013 when we\u2019re a top 5 performer in every major index but our own people can\u2019t afford to live here", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAJBVV95cUxQbElQa3hxdldIQkNjeWVRYm81TEFBcUdoN2ZsdVluOFhqbml3cHVaQUhIRXFaWm8wdjc4c09SQzNEb0pOOGxZcnJWaWRiXy1PcWNNWk5iMjJwZ0kzbHRLYUdJeTZRWXlfWFBrRUgxZFluMmVFbkhuUVRBNFdJUk1acFR0TkJUVDV3SUwtU0FzcWFPdmxmVnZhU3pLSjdVRnNqSURFOEN2ZmdRZWszUVdWZDVhSzJpWE5SV0pna0dHTGJJX2V5bGE1dGdpc1JkS3hRdHpndmxkZzFGZGN0aUFWOGhuU2dlMmdlMWNabS1GX0ZoeF83WXVmc1hocnJvaElIdFF1c3BreWg0UXBOTzNpZFEyMWtvQzlvVmlmZGQtTDI?oc=5", "source_name": "Hotpress", "published_at": "2025-08-06T07:00:00+00:00", "published_display": "06 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approval", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxPa01vX1BQRkpSQkRlRmQ3UFhobjM3c3NZZUtHTnBmQ1QtbUVzVXJScWZMZ3I0Y29fZGZhSjg1eloyLXJjd0JWaVpPX1pjTVZ1SUtCTFExbmFyMGFGMWxabmxzRkY4T2RCTWR4SVRsUE9hMTRfM1F2RS05YmtDSlhOV1RpX0VTSVdXeWNyRg?oc=5", "source_name": "Market source", "published_at": "2025-07-02T07:00:00+00:00", "published_display": "02 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What is the current Price Target and Forecast for Nutriband (NTRB)", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTE1QOUtoaFc4ZmFSUk5SNW5LUHcyWHg1YjN4c3FtXzZJMUwyei04b0pDQWVXSS1ER3AtSFdPSHUxVmRKM29oLURMWnRyZ1pwSGV1Qk1ZMlR0ZmkxUmNyQ2s5UDRuOTRGOVozM1h0QjNxRldEazNBejhfcw?oc=5", "source_name": "Zacks Investment Research", "published_at": "2022-12-02T22:08:17+00:00", "published_display": "02 Dec 2022 22:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband (NTRB) Stock Price, News & Analysis $NTRB", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTFBFSGVTTGo5OWJHSFBPT2d5TEEyTjFLdklCVXEtNFpUNzhZSW9zSjBuWExwYmNJZlNDcUpyZTMzdEFOVHZxQ1JvZ1VXV01rVGs0cEhTSVhpNnBSdw?oc=5", "source_name": "MarketBeat", "published_at": "2022-08-15T17:37:29+00:00", "published_display": "15 Aug 2022 17:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband Stock Price Forecast. Should You Buy NTRB?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiSEFVX3lxTFAzUVJLUFdmUW9ES0YwbjRkRFZveE1Gci16ZDJTUjJXUkZ5V2dtMHZYeklIVzRuSUZXLTN3OF9uSWI5dXNLWnlMMg?oc=5", "source_name": "StockInvest.us", "published_at": "2021-10-14T20:39:56+00:00", "published_display": "14 Oct 2021 20:39", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Price to book forward of Nutriband Inc. \u2013 NASDAQ:NTRBW", "summary": "This article provides financial information for Nutriband Inc. (NASDAQ: NTRBW), specifically focusing on its price-to-book forward ratio. It appears to be a financial data snippet from TradingView, indicating the company's valuation metric without further detailed analysis in thi", "url": "https://www.tradingview.com/symbols/NASDAQ-NTRBW/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-07-14T08:15:32", "published_display": "14 Jul 2026 08:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Nutriband Inc. \u2013 NASDAQ:NTRBW", "summary": "This article provides access to the \"Enterprise value to EBIT forward\" financial metric for Nutriband Inc. under the NASDAQ:NTRBW ticker symbol. It appears to be a financial data page from TradingView, offering an overview of the company's financials for market analysis. The page", "url": "https://www.tradingview.com/symbols/NASDAQ-NTRBW/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-14T05:12:48", "published_display": "14 Jul 2026 05:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband Inc. (NTRB) Slips 2.33% as Stock Tests Key Support at $2.79 - Sweep Order Flow", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPMHg5N0QwXzhpbXU0bEJLM2hmbzJiMGNTS2VBMzNtUTk0SjVUQnJKYlFCVlpLQ0x1ajRaY2xiT0ctbDF2UTJCRlcyZXVFWVNNbEhVc3lCQ2p0RkgtX2lIdkxGblRUdTlFM0N4dldvbmVTTm5hY1FOZVROd3pCeXozcG5iMXhwYU84SkItOTEtdWthbGRsWkdKclRrZDI2dFJncXdpUQ?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-13T14:48:00+00:00", "published_display": "13 Jul 2026 14:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Nutriband Inc. \u2013 NASDAQ:NTRBW", "summary": "This article focuses on the enterprise value to EBITDA forward for Nutriband Inc. (NASDAQ: NTRBW). It provides a financial metric for the company, indicating its valuation relative to its future earnings before interest, taxes, depreciation, and amortization. The content appears ", "url": "https://www.tradingview.com/symbols/NASDAQ-NTRBW/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-07-13T15:11:06", "published_display": "13 Jul 2026 15:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Nutriband Inc. \u2013 BOATS:NTRBW", "summary": "This article displays the \"Enterprise value to EBITDA forward\" for Nutriband Inc. under the symbol NTRBW on the Blue Ocean Alternative Trade System. It provides no specific financial data but indicates this metric as part of the company's financial overview on TradingView.", "url": "https://www.tradingview.com/symbols/BOATS-NTRBW/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-07-09T10:13:50", "published_display": "09 Jul 2026 10:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Nutriband Inc. \u2013 BOATS:NTRBW", "summary": "This article provides the \"Price to earnings forward\" financial data for Nutriband Inc. (NTRBW) on the Blue Ocean Alternative Trade System (BOATS). It shows that the market is currently closed with no trades recorded. The content is primarily a data point display within the Tradi", "url": "https://www.tradingview.com/symbols/BOATS-NTRBW/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-08T21:10:13", "published_display": "08 Jul 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Nutriband Inc. \u2013 BOATS:NTRBW", "summary": "The article displays the \"Price to sales forward\" financial metric for Nutriband Inc. (NTRBW) on the TradingView platform. It indicates that the market is closed and there are no trades shown for the company. The content primarily features navigation links and information about t", "url": "https://www.tradingview.com/symbols/BOATS-NTRBW/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-08T11:40:54", "published_display": "08 Jul 2026 11:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband Inc (NTRB) Valuation: PE, PB & Fair Value Analysis", "summary": "This article provides a valuation analysis of Nutriband Inc (NTRB), noting its current valuation score of 6.58, ranking 181 out of 203 in its industry. It highlights the company's P/E ratio and mentions that relevant data for P/B, P/S, and P/CF ratios have not yet been disclosed.", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ntrb/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-26T02:39:18", "published_display": "26 Jun 2026 02:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Nutriband Inc. \u2013 NASDAQ:NTRB", "summary": "This article focuses on the \"Price to sales forward\" metric for Nutriband Inc. (NASDAQ: NTRB) as presented on TradingView. It appears to be a financial data point for the company, accessible through the platform's tools for market analysis. The core content is limited to this spe", "url": "https://www.tradingview.com/symbols/NASDAQ-NTRB/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T21:11:24", "published_display": "25 Jun 2026 21:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband Inc (NTRBW) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Nutriband Inc (NTRBW), detailing its support, resistance, and various indicators. It shows that based on technical indicators like MACD, RSI, and moving averages, the current signal for NTRBW is primarily \"Sell\" with more sell signals", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ntrbw/technical", "source_name": "TradingKey", "published_at": "2026-06-25T02:39:19", "published_display": "25 Jun 2026 02:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Nutriband Inc. \u2013 NASDAQ:NTRB", "summary": "This article provides a financial data point for Nutriband Inc. (NASDAQ: NTRB), specifically its forward price-to-earnings ratio. The content presented is a snippet from TradingView's financial overview for the company, indicating the period, value, and change of this metric. It ", "url": "https://www.tradingview.com/symbols/NASDAQ-NTRB/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-24T06:40:14", "published_display": "24 Jun 2026 06:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NutriBand amends $5 million credit line facility for three more years", "summary": "NutriBand Inc. has announced an amendment to its $5 million credit line facility, extending it for three more years. The new agreement, which commenced on June 1, replaces a previous facility set to expire in July 2026, and features a 7% interest rate on drawdowns without convers", "url": "https://www.investing.com/news/sec-filings/nutriband-amends-5-million-credit-line-facility-for-three-more-years-93CH-4752601", "source_name": "Investing.com", "published_at": "2026-06-22T13:10:08", "published_display": "22 Jun 2026 13:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NutriBand Secures Amended Three-Year $5 Million Credit Line at 7% to Support AVERSA", "summary": "NutriBand (NTRB) has secured an amended three-year, $5 million credit line with a 7% interest rate. This financial agreement is intended to support the company's AVERSA fentanyl transdermal system through FDA approval and into commercial-scale manufacturing. The new facility repl", "url": "https://www.tradingview.com/news/tradingview:db7fb35430ac6:0-nutriband-secures-amended-three-year-5-million-credit-line-at-7-to-support-aversa/", "source_name": "TradingView", "published_at": "2026-06-22T12:10:08", "published_display": "22 Jun 2026 12:10", "sentiment": "positive", "sentiment_pct": 67, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[8-K] NutriBand Inc. Reports Material Event", "summary": "NutriBand Inc. (NTRB) has secured an amended three-year $5,000,000 credit line facility, replacing an expiring one, with an interest rate of 7% per annum on drawdowns. This financing is structured as straight debt, avoiding potential equity dilution, and is intended to fund the F", "url": "https://www.stocktitan.net/sec-filings/NTRB/8-k-nutri-band-inc-reports-material-event-f823572f6896.html", "source_name": "Stock Titan", "published_at": "2026-06-22T12:10:08", "published_display": "22 Jun 2026 12:10", "sentiment": "positive", "sentiment_pct": 64, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 8K Nutriband Inc For: 22 June By Investing.com", "summary": "This article reports that Nutriband Inc. filed a Form 8K on June 22, 2026. The SEC filing is noted as a key event for investors tracking the company, with its stock, NTRB, showing a 7.24% increase.", "url": "https://au.investing.com/news/stock-market-news/form-8k-nutriband-inc-for-22-june-93CH-4497674", "source_name": "Investing.com Australia", "published_at": "2026-06-22T10:10:09", "published_display": "22 Jun 2026 10:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[8-K] NutriBand Inc. Reports Material Event | NTRB 8-K Filing", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPLVh3cTRYMEstVl9pQVpWNkRyc29TYjNyd1NZOGt6Nk9GdkNmbWlnbzdnWGJBOFNLQ25fYm1WOGZxcXV5Y3hhSHpLYVVSclkwN2xkeHM1SEVvVUJIaE54YzRSMGRUVlJmQXlnTXpqMTlmUFg0aXR6VGlIQkI0dnJ3eXZGem0za3R4ejdxdHJXQkp5OUhzR3FIb3lvclZxRDRQZlYxc1dn?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband Inc (NTRBW) Risk Assessment: Volatility, Financial Risk & Investment Risk", "summary": "This article provides a risk assessment for Nutriband Inc (NTRBW), detailing various volatility and return metrics. It includes data points such as Beta vs S&P 500 index, maximum drawdown, daily returns, Sharpe Ratio, and different measures of volatility and liquidity. This infor", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ntrbw/risk-assesment", "source_name": "TradingKey", "published_at": "2026-06-19T07:39:41", "published_display": "19 Jun 2026 07:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband Inc (NTRBW) Institutional Confidence", "summary": "This article provides an overview of the institutional confidence in Nutriband Inc (NTRBW), detailing key institutional shareholders and their recent activity. It lists prominent firms like Citadel Advisors LLC, Virtu Americas LLC, Clear Street LLC, UBS Financial Services, Inc., ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ntrbw/sentiment", "source_name": "TradingKey", "published_at": "2026-06-19T03:39:41", "published_display": "19 Jun 2026 03:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband Inc (NTRBW) Financial Health: Profitability & Balance Sheet Analysis", "summary": "This article provides a financial health overview for Nutriband Inc (NTRBW), noting its current stock price and a significant daily decrease. It highlights that critical financial data regarding profitability, balance sheet, quality of earnings, operational efficiency, growth pot", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ntrbw/financial-health", "source_name": "TradingKey", "published_at": "2026-06-19T03:39:41", "published_display": "19 Jun 2026 03:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband Inc (NTRB) Institutional Confidence", "summary": "This article provides details on Nutriband Inc.'s (NTRB) institutional confidence, highlighting a score of 3.00 as of June 17, 2026. It lists key shareholders and their recent activity, showing increases in shares held by several individuals and entities, such as Botgros (Vitalie", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ntrb/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T08:10:38", "published_display": "18 Jun 2026 08:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband Inc (NTRBW) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article provides an overview of Nutriband Inc (NTRBW) shareholder structure, detailing institutional holdings and major shareholder activity. It presents data including the number of institutions and shares held over several reporting periods, as well as changes in holdings ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ntrbw/ownership", "source_name": "TradingKey", "published_at": "2026-06-18T06:09:47", "published_display": "18 Jun 2026 06:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband Inc (NTRBW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article from TradingKey attempts to provide a revenue breakdown for Nutriband Inc (NTRBW), detailing business segments, regional revenue, and profit contribution. However, the article explicitly states that the relevant data has not been disclosed by the company yet, renderi", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ntrbw/revenue", "source_name": "TradingKey", "published_at": "2026-06-18T05:09:47", "published_display": "18 Jun 2026 05:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband Inc (NTRBW) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides a detailed historical record of dividend payouts and stock splits for Nutriband Inc (NTRBW). It indicates that the company has not distributed any dividends over the past five years and has no recorded stock split events. The page also includes real-time sto", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ntrbw/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-18T05:09:47", "published_display": "18 Jun 2026 05:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband Inc (NTRB) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article from TradingKey provides a concise overview of Nutriband Inc's (NTRB) dividend history and stock split events. It indicates that Nutriband Inc has not distributed any dividends over the past five years. The only recorded stock split event for NTRB was on July 29, 202", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ntrb/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-18T00:40:36", "published_display": "18 Jun 2026 00:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband Inc (NTRB) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "Nutriband Inc (NTRB) has an earnings forecast score of 8.00, placing it well within its industry. A single analyst rates NTRB as a \"Buy\" with a target price of $15.00, suggesting a significant upside. The article provides current trading data, key financial metrics, and a peer co", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ntrb/earnings", "source_name": "TradingKey", "published_at": "2026-06-17T16:09:10", "published_display": "17 Jun 2026 16:09", "sentiment": "positive", "sentiment_pct": 70, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[10-Q] NutriBand Inc. Quarterly Earnings Report", "summary": "NutriBand Inc. (NTRB) filed its quarterly earnings report (10-Q) for the period ended April 30, 2026, showing a net loss of $1,241,956, or $0.10 per share. The company generated $433,399 in revenue, primarily from its Pocono Pharmaceuticals segment, with no revenue from 4P Therap", "url": "https://www.stocktitan.net/sec-filings/NTRB/10-q-nutri-band-inc-quarterly-earnings-report-d4e7622ab80d.html", "source_name": "Stock Titan", "published_at": "2026-06-11T20:39:55", "published_display": "11 Jun 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband Inc. (NTRB) Slips Modestly as Stock Tests Key Support Levels - Rating Change", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPbko3Q0RsWkp3cDBpaUNmekpZMlJLQlFsVVBnNUFvc2RIcm42VGFXektxX1Z3dTJ2VkVZNExNOWhBdm53cWx5TUJRcFRCeXNIMHVVRHZZVG5NOFp5LUZYV1dja1VGdmM0dWpVSWRmd3doV2EzNnpDUzB3NVhTWExlSjRYNGtLS0QtbTlDNk1WcExtSnp5WUNiaTR1WTZYZHRWb1VCOXFrQjNDSmdPZzlCbzJ6aUI5QQ?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Number of shareholders of Nutriband Inc. \u2013 NASDAQ:NTRBW", "summary": "This article provides access to the number of shareholders for Nutriband Inc. (NASDAQ: NTRBW) through TradingView's platform. It mentions that market data is provided by ICE Data Services, reference data by FactSet, and SEC filings by Quartr. The core content linked is about the ", "url": "https://www.tradingview.com/symbols/NASDAQ-NTRBW/financials-statistics-and-ratios/number-of-shareholders/", "source_name": "TradingView", "published_at": "2026-06-07T06:40:21", "published_display": "07 Jun 2026 06:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband Inc. announced that it has received $5 million in funding", "summary": "Nutriband Inc. announced it has received $5 million in funding through a creditline promissory note issued on June 1, 2026. This funding comes from a new lender, T.I.I.-Jetservices, Lda., with the note carrying a 7% interest rate and maturing on July 1, 2029. The accrued interest", "url": "https://www.marketscreener.com/news/nutriband-inc-announced-that-it-has-received-5-million-in-funding-ce7f5fdad88af522", "source_name": "www.marketscreener.com", "published_at": "2026-06-03T00:39:04", "published_display": "03 Jun 2026 00:39", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NTRB - Nutriband Inc Stock Price and Quote", "summary": "This page provides a comprehensive overview of Nutriband Inc. (NTRB) stock, including its current price, financial metrics, analyst ratings, and a detailed list of recent news and corporate actions. It highlights the company's focus on transdermal pharmaceutical products, particu", "url": "https://finviz.com/stock?t=NTRB", "source_name": "Finviz", "published_at": "2026-06-01T03:40:06", "published_display": "01 Jun 2026 03:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband, Inc. Stock Plummets to New 52-Week Low of $3.28", "summary": "Nutriband, Inc. stock has fallen to a new 52-week low of $3.28, reflecting significant financial challenges in the Pharmaceuticals & Biotechnology sector. The company reported a 42.03% decline in net sales and a 47.4% net profit loss, resulting in a negative return on equity of 1", "url": "https://www.marketsmojo.com/news/stocks-in-action/nutriband-inc-stock-plummets-to-new-52-week-low-of-328-4020949", "source_name": "Markets Mojo", "published_at": "2026-05-29T18:39:16", "published_display": "29 May 2026 18:39", "sentiment": "negative", "sentiment_pct": 19, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband Inc.'s Equity Buyback announced on September 18, 2024, has expired.", "summary": "Nutriband Inc.'s equity buyback program, which was originally announced on September 18, 2024, has now expired. The company officially ended its plan on January 31, 2026. This announcement highlights the conclusion of their share repurchase initiative.", "url": "https://www.marketscreener.com/news/nutriband-inc-s-equity-buyback-announced-on-september-18-2024-has-expired-ce7f5ad2d08ef622", "source_name": "www.marketscreener.com", "published_at": "2026-05-29T08:39:16", "published_display": "29 May 2026 08:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband, Inc. Stock Plummets to New 52-Week Low of $3.38", "summary": "Nutriband, Inc. (NTRB) has hit a new 52-week low of $3.38, with its stock declining 41.25% over the past year. The microcap pharmaceutical company faces challenges including a negative return on equity, concerning operating cash flow of -$5.64 million, and rising raw material cos", "url": "https://www.marketsmojo.com/news/stocks-in-action/nutriband-inc-stock-plummets-to-new-52-week-low-of-338-4018695", "source_name": "Markets Mojo", "published_at": "2026-05-29T02:08:59", "published_display": "29 May 2026 02:08", "sentiment": "negative", "sentiment_pct": 20, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband Inc to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/nutriband-inc-showcase-expanding-ai-110000540.html", "source_name": "GlobeNewswire", "published_at": "2026-05-15T11:00:00+00:00", "published_display": "15 May 2026 11:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl Crisis and Company Update on Latest Episode of the Jack Neel Podcast", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/nutriband-ceo-gareth-sheridan-discusses-110000956.html", "source_name": "GlobeNewswire", "published_at": "2026-04-22T11:00:00+00:00", "published_display": "22 Apr 2026 11:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband Selects Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxOZEloM2lPVjE2ZkRQbkVld0t0UU5pZlRvNzNBVnRzbjBHMVdxbzduaWNUejFaMVVWT3VpVno2UlkwbUpncTd3dERGQVFZb085RFZaaEJubXREcEY5Y3BZVkJxR1lkVGxGbGVrZzRpWkliYnFpZmthU1JNZWtIZFJDQm4tcmFYYkpMdWl0T3Q0VVc0NldaVUFITUZlSVhzQ1VSeHN0VkI3SF9uYlhzQ2xJZFZCaDZyaWdGcnpTV2dWTEdtdG83Z3BSRXhpdFl2b3ItTjJwMmZrQkt2bzBDRWlvbGNXek4?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-03-30T07:00:00+00:00", "published_display": "30 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The past five years for Nutriband (NASDAQ:NTRB) investors has not been profitable", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxPd0FZQ29mcGJlbHBrdzNWSnZlTU5hNkRyTmZLYy1sRmFTQmlxQ2FGS3FMYzJ1NGZESWl4MTRiSFUyWk1sb2pxTTlIdzhOcmtmRXpyZF82ZGMwUFVtbmpPeGZaY1h4OHRxcDZnUkhDTXI1VThBMk5fMHV5RTkycXFLN2NSNUw?oc=5", "source_name": "Market source", "published_at": "2026-01-29T08:00:00+00:00", "published_display": "29 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband responds to Trump\u2019s designation of illicit fentanyl as WMD", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPNXhhUVJ6UFNiZjhsY0lsbTBZekZwMkpuazJwX0tYQXJPQTd4SGZTb3FJbWZvVDM1Q0xQLUJnbzZHUjRpZ0FEbUZMSkp4aUFPZmtiWElRUWtLT05PQ3cxYUJscGJvWWdBSVVPdDlEREQ1RTNrSHNoOUoya2ItazFwa3FYNlpVNlFObnNWQzFuVllCdXhQelRiQW9GaEw5TTFLT1pGWVVHX21ERVVzTWIzRXRlaC1ra3llaGVaS1hWUW1jUQ?oc=5", "source_name": "Investing.com", "published_at": "2025-12-18T08:00:00+00:00", "published_display": "18 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband (NASDAQ: NTRB) Reports 51% Revenue Growth, Strong Cash Position to Advance AVERSA Fentanyl", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgJBVV95cUxQdUhQR291bHFfYXIwZTJwR19SQjhBTFdzUjVnTWd5ZVBSeVF5M25iN2NsOW1ZVkdBb3hKWWhoOHdYMndFNzgwamVhcERZNXZIeF9lUzI3NzdwR0x4cHpXVFRLMnc5UnpBVmlGOXFnb1pWRVc5YUkyZ2lsTFhXdUltbkFaeDhTTzZIc3dDWmNkN0p0NmhZSUtTc3pZWWNDN002UF9IQWlaY19XdjI3eXNSUUxmM180NDlDNHpPV2NKYWQzTHhPVGo2d1E1V3ZzaU5JQTBxTV9XMkpqM3h1SnN2OWJhdGRrOWh5TGZrdWRua2dPN1JUakVaQ29Ia0FxTXQtX2xXTGVNcnlzdjFRSUE?oc=5", "source_name": "The Globe and Mail", "published_at": "2025-09-11T07:00:00+00:00", "published_display": "11 Sep 2025 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband CEO Gareth Sheridan: \u201cThe economy is booming, but that\u2019s a punch to the gut \u2013 when we\u2019re a top 5 performer in every major index but our own people can\u2019t afford to live here", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAJBVV95cUxQbElQa3hxdldIQkNjeWVRYm81TEFBcUdoN2ZsdVluOFhqbml3cHVaQUhIRXFaWm8wdjc4c09SQzNEb0pOOGxZcnJWaWRiXy1PcWNNWk5iMjJwZ0kzbHRLYUdJeTZRWXlfWFBrRUgxZFluMmVFbkhuUVRBNFdJUk1acFR0TkJUVDV3SUwtU0FzcWFPdmxmVnZhU3pLSjdVRnNqSURFOEN2ZmdRZWszUVdWZDVhSzJpWE5SV0pna0dHTGJJX2V5bGE1dGdpc1JkS3hRdHpndmxkZzFGZGN0aUFWOGhuU2dlMmdlMWNabS1GX0ZoeF83WXVmc1hocnJvaElIdFF1c3BreWg0UXBOTzNpZFEyMWtvQzlvVmlmZGQtTDI?oc=5", "source_name": "Hotpress", "published_at": "2025-08-06T07:00:00+00:00", "published_display": "06 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approval", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxPa01vX1BQRkpSQkRlRmQ3UFhobjM3c3NZZUtHTnBmQ1QtbUVzVXJScWZMZ3I0Y29fZGZhSjg1eloyLXJjd0JWaVpPX1pjTVZ1SUtCTFExbmFyMGFGMWxabmxzRkY4T2RCTWR4SVRsUE9hMTRfM1F2RS05YmtDSlhOV1RpX0VTSVdXeWNyRg?oc=5", "source_name": "Market source", "published_at": "2025-07-02T07:00:00+00:00", "published_display": "02 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What is the current Price Target and Forecast for Nutriband (NTRB)", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTE1QOUtoaFc4ZmFSUk5SNW5LUHcyWHg1YjN4c3FtXzZJMUwyei04b0pDQWVXSS1ER3AtSFdPSHUxVmRKM29oLURMWnRyZ1pwSGV1Qk1ZMlR0ZmkxUmNyQ2s5UDRuOTRGOVozM1h0QjNxRldEazNBejhfcw?oc=5", "source_name": "Zacks Investment Research", "published_at": "2022-12-02T22:08:17+00:00", "published_display": "02 Dec 2022 22:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband (NTRB) Stock Price, News & Analysis $NTRB", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTFBFSGVTTGo5OWJHSFBPT2d5TEEyTjFLdklCVXEtNFpUNzhZSW9zSjBuWExwYmNJZlNDcUpyZTMzdEFOVHZxQ1JvZ1VXV01rVGs0cEhTSVhpNnBSdw?oc=5", "source_name": "MarketBeat", "published_at": "2022-08-15T17:37:29+00:00", "published_display": "15 Aug 2022 17:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nutriband Stock Price Forecast. Should You Buy NTRB?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiSEFVX3lxTFAzUVJLUFdmUW9ES0YwbjRkRFZveE1Gci16ZDJTUjJXUkZ5V2dtMHZYeklIVzRuSUZXLTN3OF9uSWI5dXNLWnlMMg?oc=5", "source_name": "StockInvest.us", "published_at": "2021-10-14T20:39:56+00:00", "published_display": "14 Oct 2021 20:39", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 94, "total_relevant": 52, "sentiment_summary": {"positive": 8, "negative": 3, "neutral": 41, "score": 51, "total": 52, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 75, "events": [{"event": "general", "label": "Market update", "weight": 12.1, "count": 22}, {"event": "earnings", "label": "Earnings", "weight": 8.25, "count": 17}, {"event": "liquidity", "label": "Balance sheet", "weight": 2.2, "count": 4}, {"event": "capital_return", "label": "Capital return", "weight": 2.2, "count": 4}, {"event": "guidance", "label": "Guidance", "weight": 1.45, "count": 2}, {"event": "analyst", "label": "Analyst action", "weight": 1.1, "count": 2}], "positive_events": 8, "negative_events": 3}, "market_context": {"has_market_context": true, "latest_close": 2.96, "latest_week": "2026-07-10", "one_week_move": -3.3, "four_week_move": -12.7, "twelve_week_move": -31.2, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.517405, "market_dynamics_buy_signal": false, "relative_strength": -50.66241, "fair_value_gap": -29.4, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 49.0368, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-3.3% over one week, -12.7% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 57, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 11}, {"label": "TradingKey", "count": 11}, {"label": "Market source", "count": 7}, {"label": "Stock Titan", "count": 3}, {"label": "GlobeNewswire", "count": 3}, {"label": "Investing.com", "count": 2}, {"label": "www.marketscreener.com", "count": 2}, {"label": "Markets Mojo", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 44}, {"label": "Industry context", "count": 8}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 22}, {"label": "Earnings", "count": 17}, {"label": "Balance sheet", "count": 4}, {"label": "Capital return", "count": 4}, {"label": "Analyst action", "count": 2}, {"label": "Guidance", "count": 2}, {"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "51/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "75/100 classification confidence."}, {"label": "Company focus", "value": "44", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-3.3% over one week, -12.7% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Price to book forward of Nutriband Inc. \u2013 NASDAQ:NTRBW"}], "updated_at": "2026-07-16T03:02:37.622208+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}